NOTES TO THE FINANCIAL STATEMENTS For the financial year ended 31 December 2024 24. Receivables (cont’d) Other receivables from related parties and receivables from subsidiary companies are unsecured, interest-free and are generally settled within the next 12 months in cash. The Group and Company’s receivables denominated in foreign currencies are as follows: Group Company 2024 2023 2024 2023 Rp million Rp million Rp million Rp million US Dollars 150,186 22,470 – – Singapore Dollars 1,067 808 1,067 808 Receivables that are past due but not impaired The Group has the following trade receivables that are past due at the end of the reporting period but not impaired. These receivables are unsecured and the analysis of their aging at the end of the reporting period are as follows: Group 2024 2023 Rp million Rp million Past due but not impaired: 1 - 30 days 128,529 168,914 31 - 60 days 20,793 8,917 61 - 90 days 3,330 6,018 More than 90 days 18,187 39,168 170,839 223,017 Receivables that are impaired The Group’s trade receivables that are collectively impaired at the balance sheet date and the movement of the allowance account used to record the impairment are as follows: Group 2024 2023 Rp million Rp million As at 1 January 53 175 Allowance/(write-back) for the year 391 (122) As at 31 December 444 53 Expected Credit Loss The Group had assessed that the expected credit loss allowance for trade and other receivables (except plasma receivables) is not significant and accordingly no allowance was made. Information regarding the allowance for the plasma receivables is disclosed in Note 32(a). Group Overview Financials Other information Sustainability and Governance Operation and Financial Review Annual Report 2024 137
RkJQdWJsaXNoZXIy NTkwNzg=